DK306379A - Herpesvirusvaccine - Google Patents

Herpesvirusvaccine

Info

Publication number
DK306379A
DK306379A DK306379A DK306379A DK306379A DK 306379 A DK306379 A DK 306379A DK 306379 A DK306379 A DK 306379A DK 306379 A DK306379 A DK 306379A DK 306379 A DK306379 A DK 306379A
Authority
DK
Denmark
Prior art keywords
herpes virus
virus vaccine
vaccine
virus
marek
Prior art date
Application number
DK306379A
Other languages
English (en)
Inventor
Aller W J Mc
H Z Markus
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK306379A publication Critical patent/DK306379A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK306379A 1978-07-21 1979-07-20 Herpesvirusvaccine DK306379A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92706978A 1978-07-21 1978-07-21

Publications (1)

Publication Number Publication Date
DK306379A true DK306379A (da) 1980-01-22

Family

ID=25454121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK306379A DK306379A (da) 1978-07-21 1979-07-20 Herpesvirusvaccine

Country Status (12)

Country Link
EP (1) EP0008255B1 (da)
JP (1) JPS5519271A (da)
AT (1) ATE3058T1 (da)
AU (1) AU532186B2 (da)
DE (1) DE2965191D1 (da)
DK (1) DK306379A (da)
ES (1) ES482549A0 (da)
HU (1) HU182530B (da)
IE (1) IE48379B1 (da)
PL (1) PL217216A1 (da)
PT (1) PT69953A (da)
RO (1) RO76563A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
FR2804026B1 (fr) 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
EP3246400B1 (en) 2012-01-09 2019-10-23 Sanofi Pasteur Biologics, LLC Purification of herpes virus
WO2013177172A2 (en) 2012-05-21 2013-11-28 Sanofi Pasteur Limited Herpesvirus compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof

Also Published As

Publication number Publication date
ATE3058T1 (de) 1983-04-15
DE2965191D1 (en) 1983-05-19
EP0008255A1 (en) 1980-02-20
RO76563A2 (ro) 1981-04-30
EP0008255B1 (en) 1983-04-13
ES8107300A1 (es) 1980-12-16
AU532186B2 (en) 1983-09-22
ES482549A0 (es) 1980-12-16
HU182530B (en) 1984-01-30
JPS5519271A (en) 1980-02-09
IE48379B1 (en) 1984-12-26
PL217216A1 (da) 1980-12-15
AU4882079A (en) 1980-01-24
JPS6332768B2 (da) 1988-07-01
PT69953A (en) 1979-08-01

Similar Documents

Publication Publication Date Title
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DK306379A (da) Herpesvirusvaccine
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DK0496135T3 (da) Cellefri Mareks sygdomsvirus-vaccine
DE68917138D1 (de) Toleranzinduktion gegenüber einem fremdantigen.
ATE83929T1 (de) Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen.
ATE18007T1 (de) Hepatitisimpfstoff.
EP0496787A4 (en) Novel infectious bursal disease virus
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
DK569985D0 (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
NL300073I1 (nl) Vaccin.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
ATE159758T1 (de) Azelluläre impfstoffe
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.

Legal Events

Date Code Title Description
ATS Application withdrawn